Piramal Pharma Limited, a global pharmaceuticals and wellness company, has committed to a $90 million investment plan towards expanding two of its U.S. facilities. This move comes in response to ongoing demand from U.S. customers, in support of the trend towards U.S. onshoring of drug supply, and in line with Piramal Pharma’s overall belief in the value and benefits of U.S.-based innovation. In both cases, Piramal Pharma is making brownfield expansions to existing sites, financed by bank loan...